Cargando…

Golimumab as Rescue Therapy for Refractory Immune-Mediated Uveitis: A Three-Center Experience

Objective. To evaluate, in three Spanish tertiary referral centres, the short-term safety and efficacy of golimumab (GLM) for treatment of immune-mediated uveitis resistant to previous immunosuppressive therapy. Methods. Nonrandomized retrospective interventional case series. Thirteen patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cordero-Coma, Miguel, Calvo-Río, Vanesa, Adán, Alfredo, Blanco, Ricardo, Álvarez-Castro, Carolina, Mesquida, Marina, Calleja, Sara, González-Gay, Miguel A., Ruíz de Morales, José G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058145/ https://www.ncbi.nlm.nih.gov/pubmed/24976689 http://dx.doi.org/10.1155/2014/717598

Ejemplares similares

Golimumab for the treatment of refractory juvenile idiopathic arthritis-associated uveitis
por: William, Mridula, et al.
Publicado: (2012)

Adalimumab for refractory peripheral ulcerative keratitis
por: Cordero-Coma, Miguel, et al.
Publicado: (2012)

Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
por: Lanz, Sofia, et al.
Publicado: (2021)

Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis
por: Pugliese, Daniela, et al.
Publicado: (2016)

Usefulness of Adalimumab in the Treatment of Refractory Uveitis Associated with Juvenile Idiopathic Arthritis
por: García-De-Vicuña, Carmen, et al.
Publicado: (2013)

Baricitinib in severe and refractory peripheral ulcerative keratitis: a case report and literature review
por: Calvo-Río, Vanesa, et al.
Publicado: (2022)

Efficacy and safety of immunomodulatory drugs in patients with anterior uveitis: A systematic literature review
por: Gómez-Gómez, Alejandro, et al.
Publicado: (2017)

Proinflammatory Cytokines and C-Reactive Protein in Uveitis Associated with Behçet's Disease
por: Mesquida, Marina, et al.
Publicado: (2014)

Two Functional Variants of IRF5 Influence the Development of Macular Edema in Patients with Non-Anterior Uveitis
por: Márquez, Ana, et al.
Publicado: (2013)

Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis
por: Matas, Jessica, et al.
Publicado: (2019)

Uveitis in psoriatic arthritis: study of 406 patients in a single university center and literature review
por: De Vicente Delmás, Ana, et al.
Publicado: (2023)

No Evidence of Association between Common Autoimmunity STAT4 and IL23R Risk Polymorphisms and Non-Anterior Uveitis
por: Cénit, María Carmen, et al.
Publicado: (2013)

Golimumab in adolescents with Crohn's disease refractory to previous tumour necrosis factor antibody
por: Pichler, Judith, et al.
Publicado: (2020)

Evaluation of the IL2/IL21, IL2RA and IL2RB genetic variants influence on the endogenous non-anterior uveitis genetic predisposition
por: Cénit, María Carmen, et al.
Publicado: (2013)

Comparing Prednisone and Methotrexate to Off-label Biologic Infliximab for Management of Ocular Uveitis: A Cost-minimization Analysis
por: Padula, William V., et al.
Publicado: (2015)

Golimumab for Rheumatoid Arthritis
por: Pelechas, Eleftherios, et al.
Publicado: (2019)

Development of an activity disease score in patients with uveitis (UVEDAI)
por: Pato, Esperanza, et al.
Publicado: (2016)

Tofacitinib for refractory uveitis and scleritis
por: Paley, Michael A., et al.
Publicado: (2018)

Infliximab as rescue therapy in refractory Kawasaki disease
por: Rodríguez-González, Moisés, et al.
Publicado: (2014)

Golimumab in unresponsive ulcerative colitis
por: Lippert, Elisabeth, et al.
Publicado: (2014)

Golimumab for the treatment of ulcerative colitis
por: Löwenberg, Mark, et al.
Publicado: (2014)

Golimumab in the treatment of ulcerative colitis
por: Cunningham, Georgina, et al.
Publicado: (2019)

Golimumab for the treatment of ulcerative colitis
por: Flamant, Mathurin, et al.
Publicado: (2017)

Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients
por: Martín-Varillas, José Luis, et al.
Publicado: (2022)

Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis: A retrospective study
por: Alegre-Sancho, Juan J., et al.
Publicado: (2021)

Real-life experience with 4 years of golimumab persistence in ulcerative colitis patients
por: Iborra, Marisa, et al.
Publicado: (2020)

Functionally distinct ERAP1 and ERAP2 are a hallmark of HLA-A29-(Birdshot) Uveitis
por: Kuiper, Jonas J W, et al.
Publicado: (2018)

Safety and clinical efficacy of golimumab in the treatment of arthritides
por: Simsek, Ismail, et al.
Publicado: (2010)

SAT-LB87 Golimumab Induced Thyroiditis
por: Mai, Mo M, et al.
Publicado: (2020)

Two cases of Erythrodermic psoriasis treated with Golimumab
por: Kudsi, Mayssoun, et al.
Publicado: (2022)

PReS-FINAL-2327: Abatacept in the treatment of refractory uveitis
por: Moretti, D, et al.
Publicado: (2013)

The Effect of Adalimumab in Korean Patients with Refractory Noninfectious Uveitis
por: Park, Sung Eun, et al.
Publicado: (2021)

Safety of Intravenous Methylprednisolone in Refractory and Severe Pediatric Uveitis
por: Ghoraba, Hashem H, et al.
Publicado: (2022)

Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry
por: Rahman, Proton, et al.
Publicado: (2020)

Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab
por: Vastesaeger, Nathan, et al.
Publicado: (2016)

Two years follow-up of golimumab treatment in refractory enteropathic spondyloarthritis patients with Crohn disease: A STROBE-compliant study
por: Conigliaro, Paola, et al.
Publicado: (2021)

Effectiveness of Golimumab in Clinical Management of Patients with Rheumatoid Arthritis
por: Shono, Eisuke
Publicado: (2013)

Golimumab: A Novel Anti-Tumor Necrosis Factor
por: Rossini, Maurizio, et al.
Publicado: (2013)

Erythrodermic Psoriasis Treated with Golimumab: A Case Report
por: Lee, Won-Ku, et al.
Publicado: (2015)

Ocular toxicity of intravitreal golimumab in a rabbit model
por: DURMAZ ENGİN, Ceren, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bmq1v2dv0meuf5nh69lg8nj1tc